Drug
Tbo-filgrastim
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Cytokine Release Syndrome | 27 | 34.5 | 35.6 | signal |
| 2 | Leukaemia | 8 | 20.6 | 20.8 | signal |
| 3 | Full Blood Count Decreased | 11 | 13.3 | 13.4 | signal |
| 4 | White Blood Cell Count Decreased | 52 | 11.6 | 12.3 | signal |
| 5 | Laboratory Test Abnormal | 13 | 10.7 | 10.9 | signal |
| 6 | Febrile Neutropenia | 29 | 10.6 | 11.0 | signal |
| 7 | Myelodysplastic Syndrome | 5 | 8.4 | 8.4 | signal |
| 8 | Neurotoxicity | 6 | 8.4 | 8.4 | signal |
| 9 | Blood Count Abnormal | 4 | 6.3 | 6.3 | signal |
| 10 | Acute Myeloid Leukaemia | 4 | 6.2 | 6.3 | signal |
| 11 | Plasma Cell Myeloma | 9 | 5.6 | 5.6 | signal |
| 12 | Hair Texture Abnormal | 3 | 5.4 | 5.4 | signal |